Tower Research Capital (TRC)’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,830
| Closed | -$8.8K | – | 6408 |
|
|
2023
Q3 | $8.8K | Sell |
1,830
-649
| -26% | -$3.12K | ﹤0.01% | 4302 |
|
|
2023
Q2 | $9.64K | Buy |
2,479
+62
| +3% | +$241 | ﹤0.01% | 4221 |
|
|
2023
Q1 | $7K | Sell |
2,417
-1,372
| -36% | -$3.97K | ﹤0.01% | 4812 |
|
|
2022
Q4 | $7K | Buy |
3,789
+3,307
| +686% | +$6.11K | ﹤0.01% | 4671 |
|
|
2022
Q3 | $3K | Buy |
482
+157
| +48% | +$977 | ﹤0.01% | 5500 |
|
|
2022
Q2 | $4K | Buy |
325
+287
| +755% | +$3.53K | ﹤0.01% | 5327 |
|
|
2022
Q1 | $1K | Sell |
38
-202
| -84% | -$5.32K | ﹤0.01% | 5994 |
|
|
2021
Q4 | $7K | Buy |
+240
| New | +$7K | ﹤0.01% | 4988 |
|
|
2021
Q3 | – | Sell |
-265
| Closed | -$21K | – | 6440 |
|
|
2021
Q2 | $21K | Buy |
265
+183
| +223% | +$14.5K | ﹤0.01% | 3864 |
|
|
2021
Q1 | $11K | Sell |
82
-98
| -54% | -$13.1K | ﹤0.01% | 4340 |
|
|
2020
Q4 | $29K | Sell |
180
-560
| -76% | -$90.2K | ﹤0.01% | 3611 |
|
|
2020
Q3 | $78K | Buy |
740
+566
| +325% | +$59.7K | ﹤0.01% | 3326 |
|
|
2020
Q2 | $21K | Buy |
174
+121
| +228% | +$14.6K | ﹤0.01% | 3664 |
|
|
2020
Q1 | $4K | Buy |
53
+13
| +33% | +$981 | ﹤0.01% | 2418 |
|
|
2019
Q4 | $12K | Buy |
40
+6
| +18% | +$1.8K | ﹤0.01% | 2257 |
|
|
2019
Q3 | $6K | Sell |
34
-13
| -28% | -$2.29K | ﹤0.01% | 3263 |
|
|
2019
Q2 | $19K | Sell |
47
-156
| -77% | -$63.1K | ﹤0.01% | 2231 |
|
|
2019
Q1 | $95K | Buy |
203
+182
| +867% | +$85.2K | 0.01% | 1449 |
|
|
2018
Q4 | $10K | Buy |
+21
| New | +$10K | ﹤0.01% | 2491 |
|
|
2018
Q3 | – | Sell |
-214
| Closed | -$146K | – | 4402 |
|
|
2018
Q2 | $146K | Buy |
+214
| New | +$146K | 0.01% | 1210 |
|